A shareholder’s lawsuit filed against Olympus (PINK:OCPNY) over a $1.7 billion accounting scandal is slated for a $2.6 million settlement after a federal judge granted preliminary approval to the deal last week.
Wall Street Beat
Listen to Thoratec’s Q4 2013 earnings call
Thoratec caps off 2013 and predicts healthy growth in the year to come
Inogen plans for $75M IPO
Inogen narrowed the price range for the initial public offering it registered late last year, saying it expects to price the IPO at $16 to $18 per share.
That would make the 4.4-million-share offering worth $70.6 million to $79.4 million; if the shares sell at the midpoint, Inogen would raise about $75.0 million.
CareFusion affirms full-year outlook amid 10% profit slide in Q2
Analysts are taking a cautious approach to CareFusion (NYSE:CFN) amid increasing costs and a 10% drip in profits for the company’s 2nd quarter.
Hologic swings to a loss but beats The Street
Listen to Boston Scientific’s Q4 2013 earnings call
Neovasc soars on 1st-in-human implant of Tiara transcatheter mitral valve
Smith & Nephew expands sports medicine footprint with $1.7B ArthroCare buy
Align Technology beats The Street with tripled Q4 profits
California’s Align Technology (NSDQ:ALGN) posted some very strong numbers for its 4th quarter, boosting full-year figures beyond Wall Street’s expectations.